Literature DB >> 8574501

Adaptive control of drug dosage regimens using maximum a posteriori probability Bayesian fitting.

J H Proost1.   

Abstract

Optimal drug therapy can only be achieved if a drug is given in the right dosage regimen. Therefore the dosage regimen needs to be optimized, using the available information of the drug, the patient, and his disease. The optimization of drug therapy comprises two major steps: First, the clinician should define explicit therapeutic goals for each patient individually. Second, a strategy to achieve these goals with the greatest possible precision should be chosen. An overview of the optimization of drug therapy is presented, with special reference to maximum a posteriori probability (MAP) Bayesian fitting. Drug dosage optimization requires 1. measurement of a performance index related to the therapeutic goal, generally one or more plasma concentration measurements, 2. population pharmacokinetic parameters, including mean values, standard deviations, covariances and information on the statistical distribution, and 3. reliable software for adaptive control strategy and optimal dosage regimen calculation. The benefit of optimal drug therapy by adaptive control using MAP Bayesian fitting has been proven, resulting in improved patient outcome by improved efficacy of therapy and a reduction of adverse reactions, and in reduced costs, mainly due to a reduction of hospitalization. Newer strategies might replace the MAP Bayesian fitting procedure, if their advantage has been demonstrated convincingly, and if reliable and user-friendly software is available.

Entities:  

Mesh:

Year:  1995        PMID: 8574501

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  9 in total

1.  Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction.

Authors:  Itziar Oteo; John C Lukas; Nerea Leal; Elena Suarez; Andres Valdivieso; Mikel Gastaca; Jorge Ortiz de Urbina; Rosario Calvo
Journal:  Eur J Clin Pharmacol       Date:  2012-06-03       Impact factor: 2.953

2.  External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.

Authors:  Chen-Yan Zhao; Zheng Jiao; Jun-Jun Mao; Xiao-Yan Qiu
Journal:  Br J Clin Pharmacol       Date:  2016-02-26       Impact factor: 4.335

3.  Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin.

Authors:  Stijn W van Beek; Rob Ter Heine; Ron J Keizer; Cecile Magis-Escurra; Rob E Aarnoutse; Elin M Svensson
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

4.  Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.

Authors:  Abraham J Wilhelm; Peer de Graaf; Agnes I Veldkamp; Jeroen J W M Janssen; Peter C Huijgens; Eleonora L Swart
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

5.  Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients.

Authors:  Marie Antignac; Christine Fernandez; Benoît Barrou; Mariona Roca; Jean-Louis Favrat; Saïk Urien; Robert Farinotti
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-02-24       Impact factor: 2.441

6.  Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.

Authors:  Zi-Cheng Yu; Pei-Jun Zhou; Xiang-Hui Wang; Bressolle Françoise; Da Xu; Wei-Xia Zhang; Bing Chen
Journal:  Acta Pharmacol Sin       Date:  2017-08-24       Impact factor: 6.150

Review 7.  Bayesian forecasting in paediatric populations.

Authors:  M M Fernández de Gatta; M J García; J M Lanao; A Domínguez-Gil
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

8.  Impact of gestational age and birth weight on amikacin clearance on day 1 of life.

Authors:  Michiel F Schreuder; Abraham J Wilhelm; Arend Bökenkamp; Simone M H Timmermans; Henriette A Delemarre-van de Waal; Joanna A E van Wijk
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

9.  Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients.

Authors:  Chantal Le Guellec; Hélène Bourgoin; Matthias Büchler; Yann Le Meur; Yvon Lebranchu; Pierre Marquet; Gilles Paintaud
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.